Month: November 2023

Biomea Fusion Abstract “BMF-219: A Novel Therapeutic Agent to Reestablish Functional Beta Cells and Provide Long-term Glycemic Control” Selected as One of Six Oral Presentations at 21st World Congress Insulin Resistance, Diabetes & Cardiovascular Disease

Harbour Coca Approved to Commercially Distribute Coca Leaf Internationally Following Landmark Trade Agreement with Peruvian State-Run Coca Leaf Producer

Harbour Becomes Authorized Agent of Coca Globally, Permitting the Distribution of Ethically Sourced, High-Quality Coca Leaf For Emerging OpportunitiesToronto, Ontario--(Newsfile...

Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Toronto, Ontario--(Newsfile Corp. - November 16, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...

SportsMD and Andy Roddick’s ViewFi Partner to Provide Telehealth Sports Medicine Care to Athletes and Youth Sports Across the US

FAIRFIELD, Conn & ATLANTA--(BUSINESS WIRE)--SportsMD.com, the premier online sports medicine resource providing content and care for athletes, announced a partnership...

Gratia Health Emerges From Stealth With ScionHealth Partnership to Support Frontline Caregivers With Its Incentive Compensation Platform

Now live at 70-plus hospitals nationwide, Gratia has supported employees while helping health system reduce contract nursing labor costsAUSTIN, Texas--(BUSINESS...

Inhalon Biopharma Secures U.S. Army Medical Research and Development Command Award to Support Development of Inhaled Therapeutics for Treatment of COVID-19

U.S. Army-Funded Project Will Support Further Development of Novel Therapeutic ModalityDURHAM, N.C.--(BUSINESS WIRE)--Inhalon Biopharma, a clinical-stage company advancing a proprietary...

FSD Pharma Files Supplement to Management Information Circular in Connection with Special Meeting to be Held on November 20, 2023

TORONTO, ON / ACCESSWIRE / November 15, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical...

error: Content is protected !!